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THE ROLE OF FAS WITH FAS LIGAND INTERACTION IN HERPETIC
STROMAL KERATITIS (HSK)

Abstract:
Herpes Simplex Virus (HSV)-induced herpetic stromal keratitis (HSK) is a leading cause
of infectious blindness world wide. The pathogenesis of this disease involves an
inflammatory attack in the cornea following infection or reactivation of HSV-1. Previous
studies have shown that the apoptotic molecule Fas ligand (FasL) is very important in
controlling inflammatory responses that occur in the cornea. Consequently we decided to
investigate the role that Fas, the receptor for FasL, and FasL play during HSK. To that
end, previous studies done by others in the lab have shown that mice which do not
express the Fas antigen (lpr) have particularly enhanced HSK. The focus of this project
was to determine whether the lack of functional Fas expression by lymphoid cells was
responsible for the disease phenotype seen in lpr mice. In order to investigate this we
created bone marrow chimeras between BALB/c and BALB-lpr mice which were
subsequently infected with HSV-1. Our results indicate that irradiated BALB/c mice
reconstituted with BALB-lpr bone marrow had significantly worse corneal disease than
did irradiated BALB-lpr mice reconstituted with BALB/c bone marrow as evident by
increased opacity, neovascularization and blepharitis scores in these mice.
Thus our data confirm the hypothesis that FasL controls the entry of Fas-expressing
inflammatory cells during acute HSK.
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Introduction:
Herpes Simplex Virus is a double stranded DNA virus. It belongs to the Simplexvirus
genus with two species, HSV-1 and HSV-2. The prevalence of HSV infection varies
among different regions and populations in the world. HSV-1 prevalence is high in
United States while more cases of HSV-2 are reported for sub-Saharan African women
and to a lesser degree in men (34). HSV-1 infection mostly occurs during childhood and
adolescence and is more common than HSV-2 infection. Herpes Simplex Virus (HSV)induced herpetic stromal keratitis (HSK) is usually caused by HSV1 and is a leading
cause of infectious blindness in humans worldwide (1, 2), and probably the leading cause
in the United States (3). It is estimated that there are 500,000 cases of ocular HSV
infections annually in the United States alone (4). Of these cases, approximately 20%
will develop stromal disease, which can lead to permanent scarring of the cornea and loss
of vision (1, 5). The disease is believed to be immune-mediated in which several
different subsets of lymphoid cells have been implicated, including T cells, neutrophils,
and macrophages (6-10). The roles of each of these cell types have not been fully
determined, nor has the mechanism of tissue damage been clearly delineated. Although
primary HSV-1 infection in mice included multiple symptoms and phenotypes, it is the
recurrent infection that presents clinical features such as microdendrites, focal stromal
opacities, disciform endothelitis and cornea neovascularization which are similar to those
observed in humans (11). Loss of vision typically occurs following several episodes of
re-activation of latent HSV from the trigeminal ganglia (11). Thus an understanding of
the cellular interactions between viral specific immune cells and the cornea and nervous
system are crucial in determining the underlying mechanisms of this disease. Such an

1

understanding is critical in designing effective vaccines and therapies that will prove
useful in treating HSK.
In the face of this potentially blinding inflammatory attack, the cornea has the ability to
reduce inflammation. These include the presence of immunosuppressive factors such as
TGF-β, reduced MHC expression on dendritic cells (33) and the presence of Fas ligand
(FasL) (12-17). It is the presence of FasL that is the focus of this project. FasL is a typeII transmembrane protein and Fas is a transmembrane receptor in the tumor necrosis
(TNF) receptor gene family. FasL binding with the Fas receptor results in apoptosis or
cell death of inflammatory cells upon infection. When these two genes are defective, the
presence of inflammatory cells could lead to disease progression and manifestation. The
interaction of FasL with Fas receptor plays an important role in the regulation of the
immune system and cancer progression.
Various studies have clearly demonstrated that the presence of FasL in the eye is an
important barrier to both inflammatory cells (12-14) and new blood vessels (15-17), both
of which are intimately involved in the pathology of HSK. Control of inflammation is
also known to be a significant component of the immune privilege of the eye (12, 13).
FasL expressed on ocular tissues induces apoptosis in Fas+ lymphoid cells that invade the
eye in response to viral infection (12) or corneal grafting (14). FasL expressed in the
retina and the cornea also controls new vessel growth beneath the retina and in the cornea
by inducing apoptosis of Fas expressing vascular endothelial cells (18-20). These studies
clearly indicate that the presence of FasL in ocular tissues restricts inflammatory
responses. In fact preliminary data from this laboratory indicates that mice expressing
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mutations in either Fas (lpr) or FasL (gld) display significantly greater ocular disease
than do wild-type mice during both primary and recurrent HSK.
In this study, we intended to more fully investigate the role that Fas-FasL interaction
plays during HSK in lpr (having mutation in Fas gene) mice. Since the mutation is
expressed by both lymphoid and non-lymphoid cells, the relevant cell expressing the lpr
mutation that gives rise to the increased phenotype was not identified. We predicted that
mice with a lymphoid system expressing the lpr mutation will show greater HSK than
mice with wild type lymphoid cells regardless of the Fas phenotype of all other cells
within the mouse. We tested this hypothesis by constructing bone marrow chimeras
between BALB/c (control) and BALB-lpr (with mutation in Fas gene) mice and infecting
them with the KOS strain of HSV-1. Clinical disease (stromal opacification, corneal
neovascularization and blepharitis (disease of the eye lid)) was scored every week for
four weeks post infection. Results confirmed our hypothesis that increased HSK
observed in lpr mice was due to lack of functional Fas on lymphoid cells.

Methods and materials:
Mice:
We purchased 6 week old BALB/c (control) mice from Jackson Laboratory. The BALBlpr (BALB/c mice with mutation in Fas gene) mice were produced in our laboratory by
backcrossing C57BL/6-lpr (C57BL/6 mice with mutation in Fas gene) mice to BALB/c
mice for 12 generations and maintained by brother sister mating. These mice are
maintained in an ALARA accredited facility at Saint Louis University. All investigations
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with these mice conformed to the Association for Research in Vision and Ophthalmology
(ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research.
Bone Marrow Chimeras:
Radiation bone marrow chimeras between BALB/c and BALB-lpr mice were prepared as
described (11). Briefly, bone marrow and spleen cells were extracted from a pool of wild
type (BALB/c) mice. Bone marrow and spleen cells were extracted from a pool of lpr
(Fas negative or having mutation in Fas gene) mice. A group of wild type and a group of
lpr mice were irradiated with 700 Rads from an XRAD 320 irradiator (Precision X-Ray,
North Branford, CT) to kill all their bone marrow cells. Subsequently, the wild type mice
were given an equal mixture of 2x107 bone marrow and spleen cells from lpr mice and
the lpr mice were given an equal mixture of 2x107 bone marrow and spleen cells from
BALB/c mice. The level of chimerism was determined by PCR genotype analysis of
peripheral blood cells 30 days after bone marrow transplantation. These mice were then
infected 50 days following bone marrow reconstitution and phenotypic differences were
observed over time.
Infection with HSV-1:
The viruses used in this study were of the KOS strain of HSV-1. A plaque-purified stock
was grown and assayed on Vero cells in minimum essential medium with Earle’s
balanced salts (MEM-EBS) containing 5% fetal bovine serum, 100 U penicillin ml-1 and
100ug Streptomycin ml-1 (21). Chimera mice were infected as described previously (22).
Briefly, following corneal scarification, 2 x 107 pfu of HSV-1 KOS strain in 5ul MEMEBS was placed onto the surface of both corneas of each mouse.
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Quantitation of virus in tear film swabs:
Vero cells were seeded in 48 well plates containing growth media. Cell growth media
was prepared by using 1000ml DMEM media (Sigma D6546) supplemented with 5%
FBS (Atlanta biological S11150), 10ml 100x pen/strep, 1ml 1000x fungizon, and 10ml LGlutamine (Sigma G7513). Briefly 100ul of eye swab material was used to infect 90%
confluent Vero cells in 48 well plates. Eye swabs were assayed for the presence of virus
by standard plaque assay (22) 48 hours following addition of eye swab material.
Clinical evaluation
On the designated days after viral infection, a masked observer examined mouse eyes
through a binocular-dissecting microscope in order to score clinical disease. Stromal
opacification was rated on a scale of 0 to 4, where 0 indicates clear stroma, 1 indicates
mild stromal opacification, 2 indicates moderate opacity with discernible iris features, 3
indicates dense opacity with loss of defined iris detail except pupil margins, and 4
indicates total opacity with no posterior view. Corneal neovascularization was evaluated
as described (21) using a scale of 0-8, where each of four quadrants of the eye is
evaluated for the amount of vessels that have grown into them. Periocular disease was
measured in a masked fashion on a semiquantitative scale as previously described (23).
Statistical analysis:
The descriptive statistics were used to draw mean and standard error of mean values. The
unpaired t test was used for comparing means between groups of mice. The t test for two
sample assuming unequal variances were used to compare data for different time points
within the same group.
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Results:
Previous work from this laboratory, as well as others, has indicated that the expression of
FasL in the eye is a critical factor in limiting inflammatory responses there (24, 12, 25,
and 26). To that end recent work has demonstrated that mice carrying mutations in either
Fas (lpr) or FasL (gld) exhibited increased HSK, as determined by opacity and
neovascularization than seen in wild-type BALB/c mice following infection with HSV-1,
KOS strain (Fig. 1). Interestingly, only BALB-lpr mice demonstrated significant
blepharitis scores following infection with HSV-1, KOS strain (Fig. 2).

Figure 1A
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Figure 1B

Figure 1: Defective expression of both Fas and to a lesser extent FasL, results in increased HSK following infection with HSV-1,
KOS strain. Eyes of BALB/c wild-type (n=30), BALB-lpr (n=25) and BALB-gld (n=25) mice were infected with 107 pfu of HSV-1,
KOS strain. Corneal opacity (A) and corneal neovascularization (B) were measured and compared between these strains of mice.
Significant virus-induced corneal opacity was observed for BALB-lpr (P<0.01) at all time points when compared to BALB/c controls.
BALB-gld mice displayed significantly more opacity than did BALB/c controls at days 14-35 (P<0.05-0.01). BALB-lpr displayed
significantly greater neovascularization at days 11-41 (P<0.05-0.01) and BALB-gld mice had greater neovascularization at days 14-22
(P<0.05-0.01) than did BALB/c controls. Results displayed are means + S.E.M. for each of the groups of mice indicated. Student t
test was used for statistical analysis. This is an unpublished observation by Jessica E. Morris etal.
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Figure 2

Figure 2: Defective expression of Fas but not FasL, results in increased blepharitis following infection with HSV-1, KOS strain. Eyes
of BALB/c wild-type (n=20), BALB-lpr (n=20) and BALB-gld (n=20) mice were infected with 107 pfu of HSV-1, KOS strain and
blepharitis measured. Significant virus-induced blepharitis was observed for BALB-lpr (P<0.01) at days 14 and 21 when compared to
both BALB/c controls and BALB-gld mice. Results displayed are means + S.E.M. for each of the groups of mice indicated. Student
t test was used for statistical analysis. This is an unpublished observation by Jessica E. Morris etal.

Since both lymphoid (inflammatory cells (12-14)), and non-lymphoid cells (vascular
endothelium (16,17)) can express Fas, it is possible that the disease seen in lpr mice
following corneal infection with HSV-1 is due to the lack of Fas expression on either one
or both of these general types of cells. We have shown that resident cells of the cornea do
not express Fas (27) and thus should not play a role in corneal disease. Consequently, we
hypothesized that the cells responsible for the severity of HSK phenotype in lpr mice are
bone marrow derived. We believed that increased disease is due to uncontrolled
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infiltration of the corneas by lymphoid cells which are not susceptible to FasL-mediated
lysis. To test this hypothesis, we decided to produce bone marrow chimeric mice between
BALB/c and BALB-lpr mice to identify the relevant cell population for the lpr
phenotype. Two months following bone marrow reconstitution of these mice, we infected
their corneas with HSV-1, KOS stain. Our data indicates that BALB/c mice that are
reconstituted with BM cells from lpr mice display significantly greater corneal disease
than do BALB-lpr mice that are reconstituted with BALB/c BM cells at 2 and 3 weeks
following infection (Fig. 3-5). It should also be pointed out that mice possessing BALBlpr BM also presented other indications of increased disease as evidenced by hunched
posture and weight loss, which were not seen in BALB-lpr mice receiving BALB/c BM
cells.
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Figure 3: Defective expression of Fas, results in increased HSK following infection with HSV-1, KOS strain. Eyes of BALB/c
chimera (n=20) and BALB-lpr chimera (n=8) mice were infected with 107 pfu of HSV-1, KOS strain. Corneal opacity was measured
and compared between these two groups of mice. Significant virus-induced corneal opacity was observed for BALB/c chimera mice
at week 1 (P<0.05) and week 3 (P<0.01) post infection when compared to BALB-lpr chimera mice. Results displayed are means +
S.E.M. for each of the groups of mice indicated. The mean corneal opacity for each of the four weeks observed for Balb/c chimera
mice differ significantly (p<0.05) from that of BALB-lpr chimera mice. Student t test was used for statistical analysis.
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Figure 4
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Figure 4: Defective expression of Fas, results in increased HSK following infection with HSV-1, KOS strain. Eyes of BALB/c
chimera (n=20) and BALB-lpr chimera (n=8) mice were infected with 107 pfu of HSV-1, KOS strain. Corneal neovascularization was
measured and compared between these two groups of mice. Significant (p<0.05) virus-induced corneal neovascularization was
observed for Balb/c chimera mice at three weeks post infection when compared to BALB-lpr chimera mice. Student t test was used
for statistical analysis. Results displayed are means + S.E.M. for each of the groups of mice indicated.
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Figure 5
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Figure 5: Defective expression of Fas, results in increased HSK following infection with HSV-1, KOS strain. Eyes of BALB/c
chimera (n=20) and BALB-lpr chimera (n=8) mice were infected with 107 pfu of HSV-1, KOS strain. Significant virus-induced
blepharitis was observed for BALB/c chimera mice at week 2 (P<0.05) and week 3 (P<0.01) post infection when compared to BALBlpr chimera mice. Student t test was used for statistical analysis. Results displayed are means + S.E.M. for each of the groups of mice
indicated.

Another possible reason for increased disease could be that following infection with
HSV-1 the inflammatory cells entering the corneas of BALB-lpr do not clear virus as
quickly as do BALB/c mice. Thus, when HSV-1 virus persists in the cornea this could
lead to potentially stronger inflammatory responses due to impaired clearance of virus.
Previous studies have indicated that virus does persist in the corneas of parental BALBlpr mice for 2-4 days longer than in BALB/c mice. To assess the viral persistence in
chimeric mice we took eye swabs from mice for the first 9 days following infection. The
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presence of virus was then assayed by plating on the HSV-1 susceptible VERO cells.
Results indicated that both types of chimeric mice cleared virus by day 9 following
infection and that the number of mice displaying positive eye swabs at both day 6 and
day 7 were not significantly different (31% for BALB/c mice with BALB-lpr BM and
28% for BALB-lpr mice with BALB/c BM. Consequently, our results do not support the
thesis that persistence of virus in chimeric mice is responsible for increased disease.
Figure 6

Figure 6: Defective expression of Fas and FasL, does not increase the magnitude of corneal viral shedding but does prolong shedding.
Eyes of BALB/c wild-type (n=30), BALB-lpr (n=25) and BALB-gld (n=25) mice were infected with 107 pfu of HSV-1, KOS strain
and corneas were swabbed on the indicated days and then tittered. No significant differences were seen in the magnitude of viral
shedding. Student t test was used for statistical analysis. Results displayed are means + S.E.M. for each of the groups of mice
indicated. This is an unpublished observation by Jessica E. Morris etal.
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Discussion:
One of the prime mechanisms the eye uses to protect itself from T cell–mediated
immunopathologic response is the presence of FasL which induces apoptosis in Fas+
lymphoid cells (28). Our laboratory, as well as several others have shown that lack of
functional Fas-FasL-mediated apoptotic ability in the eye most often leads to increased
inflammatory responses (12), increased corneal allograft rejection (13,29), increased
neovascularization (17) and the inability to develop systemic tolerance following
injection of antigen into the anterior chamber (13). In addition to these responses that are
specific to the eye, it is also well established that host T cells eliminate viral infected cells
by either the perforin-granzyme pathway (30) or via apoptosis mediated by the
interaction of FasL on effector cells with Fas expressed by virally infected cells (31,32).
Thus it would seem that mice that are not able to express either functional FasL or their
receptor Fas have the potential of expressing a wide variety of abnormalities. These
might include being more prone to greater inflammatory responses in tissues such as the
eye where FasL plays such a large role in controlling inflammation. One might also
hypothesize that they would have difficulty clearing virally infected cells because that
pathway of killing is not available to them.
We decided to investigate the role that Fas, the receptor for FasL, and FasL play during
HSK. Previous studies done by others in the lab have shown that mice which do not
express the Fas antigen (lpr) have particularly enhanced HSK (see Figures 1 and 2). The
focus of this project was to determine whether the lack of functional Fas expression by
lymphoid cells was responsible for the disease phenotype seen in lpr mice. In order to
investigate this we created bone marrow chimeras between BALB/c and BALB-lpr mice
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which were subsequently infected with HSV-1. Our results indicate that irradiated
BALB/c mice reconstituted with BALB-lpr bone marrow had significantly worse corneal
disease than did irradiated BALB-lpr mice reconstituted with BALB/c bone marrow as
evident by increased opacity, neovascularization and blepharitis scores in these mice (see
Figures 3-5).
We also examined these chimeric mice to determine if viral persistence was a factor in
increased disease phenotype. However, there were no differences in the persistence of
HSV-1 in the corneas of the chimeric mice, as both cleared virus with the same kinetics.
Thus viral persistence cannot be a mechanism responsible for increased HSK seen in
chimeric BALB/c mice with BALB-lpr lymphoid cells.
Prior to these studies, it had been possible to agree that the increased disease seen in lpr
mice could have been due to lack of control of neovascularization as vascular
endothelium expresses Fas and neovascularization of the cornea has been shown to be
controlled by corneal expression of FasL (17). However, we thought that was unlikely as
lpr mice express normal Fas on their vascular endothelium (17). By demonstrating that
the disease phenotype is associated with lymphoid cells, this further supports the notion
that vascular endothelial expression of Fas alone is not responsible for increased HSK in
BALB-lpr mice. This however does not rule out the possibility that lack of Fas
expression by vascular endothelium plays some role in ocular disease, but it is not the
sole or even a major contributor to the disease phenotype seen in BALB-lpr mice.
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Taken together, our data confirm the hypothesis that lack of FasL-mediated control of
Fas-expressing inflammatory cells is responsible for the increased disease phenotype seen
in BALB-lpr mice.
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